WO2000067009A1 - Tampons melanges dans des systemes d'electrophorese en gel - Google Patents
Tampons melanges dans des systemes d'electrophorese en gel Download PDFInfo
- Publication number
- WO2000067009A1 WO2000067009A1 PCT/US2000/011474 US0011474W WO0067009A1 WO 2000067009 A1 WO2000067009 A1 WO 2000067009A1 US 0011474 W US0011474 W US 0011474W WO 0067009 A1 WO0067009 A1 WO 0067009A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- separation
- range
- electrophoresis
- polymeric material
- biomolecules
- Prior art date
Links
- 239000000872 buffer Substances 0.000 title claims abstract description 41
- 238000001502 gel electrophoresis Methods 0.000 title abstract description 18
- 238000000926 separation method Methods 0.000 claims abstract description 78
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 71
- 238000000034 method Methods 0.000 claims abstract description 70
- 238000001962 electrophoresis Methods 0.000 claims abstract description 64
- 239000000463 material Substances 0.000 claims description 54
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 32
- 229920002401 polyacrylamide Polymers 0.000 claims description 29
- 230000005684 electric field Effects 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 24
- 229920000642 polymer Polymers 0.000 claims description 24
- -1 poly(ethylene glycol) Polymers 0.000 claims description 20
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 19
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 15
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 12
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 12
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 239000000017 hydrogel Substances 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 8
- 235000013877 carbamide Nutrition 0.000 claims description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 6
- 239000007983 Tris buffer Substances 0.000 claims description 6
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 claims description 6
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims description 6
- 229920001223 polyethylene glycol Polymers 0.000 claims description 6
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 5
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 5
- 239000004202 carbamide Substances 0.000 claims description 5
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 claims description 5
- 150000002576 ketones Chemical class 0.000 claims description 5
- 150000002825 nitriles Chemical class 0.000 claims description 5
- 239000003880 polar aprotic solvent Substances 0.000 claims description 5
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 claims description 4
- 229920006322 acrylamide copolymer Polymers 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- YPEMKASELPCGPB-UHFFFAOYSA-N 2-methylprop-2-enoic acid;prop-2-enamide Chemical compound NC(=O)C=C.CC(=C)C(O)=O YPEMKASELPCGPB-UHFFFAOYSA-N 0.000 claims description 3
- 229920000936 Agarose Polymers 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 3
- OHLUUHNLEMFGTQ-UHFFFAOYSA-N N-methylacetamide Chemical compound CNC(C)=O OHLUUHNLEMFGTQ-UHFFFAOYSA-N 0.000 claims description 3
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 claims description 3
- 229960002327 chloral hydrate Drugs 0.000 claims description 3
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 claims description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 3
- QRIMLDXJAPZHJE-UHFFFAOYSA-N 2,3-dihydroxypropyl 2-methylprop-2-enoate Chemical group CC(=C)C(=O)OCC(O)CO QRIMLDXJAPZHJE-UHFFFAOYSA-N 0.000 claims description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims description 2
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 2
- JJWSNOOGIUMOEE-UHFFFAOYSA-N Monomethylmercury Chemical compound [Hg]C JJWSNOOGIUMOEE-UHFFFAOYSA-N 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004743 Polypropylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- ZTOMUSMDRMJOTH-UHFFFAOYSA-N glutaronitrile Chemical compound N#CCCCC#N ZTOMUSMDRMJOTH-UHFFFAOYSA-N 0.000 claims description 2
- 125000005395 methacrylic acid group Chemical group 0.000 claims description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920005554 polynitrile Polymers 0.000 claims description 2
- 229920001155 polypropylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 2
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 claims description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 6
- JHPBZFOKBAGZBL-UHFFFAOYSA-N (3-hydroxy-2,2,4-trimethylpentyl) 2-methylprop-2-enoate Chemical compound CC(C)C(O)C(C)(C)COC(=O)C(C)=C JHPBZFOKBAGZBL-UHFFFAOYSA-N 0.000 claims 1
- 125000003158 alcohol group Chemical group 0.000 claims 1
- 239000012620 biological material Substances 0.000 abstract description 11
- 239000000499 gel Substances 0.000 description 116
- 239000002609 medium Substances 0.000 description 32
- 235000018102 proteins Nutrition 0.000 description 26
- 108090000623 proteins and genes Proteins 0.000 description 26
- 102000004169 proteins and genes Human genes 0.000 description 26
- 239000003792 electrolyte Substances 0.000 description 15
- 239000011148 porous material Substances 0.000 description 14
- 239000012736 aqueous medium Substances 0.000 description 12
- 230000002209 hydrophobic effect Effects 0.000 description 11
- 230000005012 migration Effects 0.000 description 11
- 238000013508 migration Methods 0.000 description 11
- 150000002632 lipids Chemical class 0.000 description 9
- 239000000523 sample Substances 0.000 description 9
- 150000001720 carbohydrates Chemical class 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 238000004132 cross linking Methods 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 6
- 238000007873 sieving Methods 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 241000894007 species Species 0.000 description 5
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 5
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 229930186217 Glycolipid Natural products 0.000 description 4
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000008151 electrolyte solution Substances 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 239000000178 monomer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000002528 anti-freeze Effects 0.000 description 3
- 229920001400 block copolymer Polymers 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000012160 loading buffer Substances 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000012146 running buffer Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical group OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- DGZSVBBLLGZHSF-UHFFFAOYSA-N 4,4-diethylpiperidine Chemical compound CCC1(CC)CCNCC1 DGZSVBBLLGZHSF-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229920002301 cellulose acetate Polymers 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 150000002170 ethers Chemical class 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000020169 heat generation Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920002521 macromolecule Polymers 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 125000002560 nitrile group Chemical group 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- XLPJNCYCZORXHG-UHFFFAOYSA-N 1-morpholin-4-ylprop-2-en-1-one Chemical compound C=CC(=O)N1CCOCC1 XLPJNCYCZORXHG-UHFFFAOYSA-N 0.000 description 1
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 108010053481 Antifreeze Proteins Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- XYZZKVRWGOWVGO-UHFFFAOYSA-N Glycerol-phosphate Chemical compound OP(O)(O)=O.OCC(O)CO XYZZKVRWGOWVGO-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 238000005460 biophysical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- TWIAWFLIJOWHFQ-UHFFFAOYSA-N boric acid methylaminomethanol Chemical compound CNCO.CNCO.CNCO.OB(O)O TWIAWFLIJOWHFQ-UHFFFAOYSA-N 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229930183167 cerebroside Natural products 0.000 description 1
- 150000001784 cerebrosides Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010382 chemical cross-linking Methods 0.000 description 1
- 238000003508 chemical denaturation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000004665 fatty acids Chemical group 0.000 description 1
- 125000002519 galactosyl group Chemical group C1([C@H](O)[C@@H](O)[C@@H](O)[C@H](O1)CO)* 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 238000003505 heat denaturation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000010399 physical interaction Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 108091033319 polynucleotide Proteins 0.000 description 1
- 102000040430 polynucleotide Human genes 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000010526 radical polymerization reaction Methods 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000012723 sample buffer Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- PIEPQKCYPFFYMG-UHFFFAOYSA-N tris acetate Chemical compound CC(O)=O.OCC(N)(CO)CO PIEPQKCYPFFYMG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44747—Composition of gel or of carrier mixture
Definitions
- the present invention relates to gel electrophoresis, and particularly to improved methods for the separation of biological materials using gel electrophoresis.
- Gel electrophoresis is a technique that is often carried out for the analysis and purification of biological molecules such as peptides, proteins, nucleic acids, carbohydrates, and others. Electrophoresis is based on the principle that charged molecules will migrate when placed in an electric field, with the rate of migration dependent upon, among other things, the molecule's charge density (charge per unit of mass). Gel electrophoresis uses a gel, made of natural or synthetic polymers, typically manufactured in a slab orientation or alternatively in a tube shape, to provide a support for the molecules so that they can be analyzed at the completion of separation, and to provide additional sieving characteristics.
- Gels for electrophoresis can be considered to consist of random networks of filaments, cross-linked by covalent, ionic, hydrogen or other molecular bonds, to form a three-dimensional "sponge".
- the pores form a molecular sieve that retards the mobility of molecules migrating in the imposed electric field.
- the size of the pores is determined by the concentration of filaments (normally described as the percentage of solid in the gel) and the degree of cross-linking. For two molecules with equal charge density, their migration through the gel will be determined by their size.
- the rate of migration is inversely proportional to the log of the protein molecular weight over a limited range of molecular weights, so that smaller molecules migrate at a faster rate than those of larger size.
- Gel electrophoresis is typically performed by placing a complex mixture of molecules to be separated and analyzed or purified at one position in the gel by means of a well formed in the gel or by means of layering at one end of a tube.
- the mixture usually contains a visible dye that migrates at a known rate in the system.
- the gel is brought into contact with an electrolyte buffer solution that is in electrical contact with a power source, and a defined electrical field is applied to the gel.
- the molecules in the sample migrate toward the appropriate electrode, each at an individual rate until the marker dye reaches a predetermined position in the gel.
- the electrical field is then removed and the separated molecules are visualized by one or more methods well known in the field as bands corresponding in width to the width of the sample well. The size, relative concentration and other information on the molecules in the sample can then be determined.
- nucleic acids the charge density of each molecule is approximately equal, since each individual nucleotide has one charged moiety. Care is taken to remove any possible tertiary structure from RNA and DNA, and any secondary structure from RNA and DNA for determinations based on specific sequence characteristics, typically by using a combination of heat and chemical denaturation. As a result, nucleic acids are typically separated based on their primary sequence length.
- the extent of molecular sieving is thought to depend on how closely the gel pore size approximates the size of the migrating particle.
- the pore size of agarose gels is sufficiently large that molecular sieving of most protein molecules is minimal and separation of proteins is based mainly on charge density.
- polyacrylamide gels can have pores that more closely approximate the size of protein molecules and so contribute to the molecular sieving effect.
- Polyacrylamide has the further advantage of being a synthetic polymer which can be prepared in highly purified form.
- Polymeric materials consisting of block copolymers of partially hydrolyzed acrylonitrile have also been demonstrated to be of utility in the separations of biological materials (US Patent 5,888,365).
- Gels are typically saturated with an electrolyte solution that provides for efficient electrical conductivity.
- the rate of biomolecule migration in gel electrophoresis is also affected by the concentration and type of ions present in the electrolyte solution.
- the concentration of ions in the electrolyte solution must be high enough that the counter- ions keeping the biological molecule in solution are not separated from the biomolecule (which is itself a large ionic species), in which case the force attracting the large ion to the small counter-ions can become stronger than the electromotive force of the applied electric field.
- Electrolyte concentrations that are too great lead to degradation of molecule band resolution.
- the pH of the electrolyte also plays a role in maintaining electrophoretic separation.
- the electrolyte solution also contains a buffering system, typically based upon tris(hydroxy-methyl)aminomethane (Tris).
- sample buffer is used to prepare the biological materials for separation under a given set of electrophoretic conditions.
- electrode buffer is used as a conducting medium, among other functions, to conduct the electrical potential from the electrode to the gel, which causes the charged biological molecules to migrate and separate in the gel.
- gel buffer which impregnates the gel media so as to cause the biological molecules to migrate and resolve themselves according to their size and charge under electrophoretic conditions.
- Gel buffers are often chosen so that the media has a suitable pH value for biological molecules to carry desired charges under a given set of electrophoretic conditions.
- the buffer type and ionic strength are also factors of consideration for achieving the optimal results of (a) controlling the pore size of the gel for sieving and (b) controlling and balancing the heat generation and the speed of separation.
- Tris-HCl Tris-Borate
- Tris-acetate Tris-acetate
- the electrode buffer often consists of a Tris-glycine system, or the like.
- electrolyte components such as SDS in the buffer system, but it has been very uncommon in the past for organic agents such as ethanol, methanol, acetonitrile, and the like to be added to gel buffer systems for use in electrophoretic applications.
- polyacrylamide is a very hydrophilic material whose polymerization is adversely affected by some agents that interfere with the free-radical initiated polymerization of polyacrylamide, resulting in lack of gelation, opaque gels, gels with reduced separation capacity, and other problems.
- some organic agents have been used in combination with polyacrylamide and other polymer gels, most notably sulfolane, dimethyl formamide (DMF), urea, and phenol. These agents have been added to polyacrylamide gels with the intent of denaturing or solubilizing otherwise insoluble, hydrophobic biomolecules to make gel electrophoresis possible.
- Electrophoresis 1992, 13:824-831 reports the use of TMU, DMF, formamide, methanol, ethanol, DMSO, sulfolane, n-methylacetamide, N- methylpyrrolidinone and tetrahydrofuran to reswell dried polyethyleneglycol methacrylate/polyacrylamide gels, and suggests that the agents are compatible with this copolymer system.
- This paper describes experiments designed to allow for separation of extremely hydrophobic proteins and notes the gels studied "as a whole have less rapid protein migration and poorer resolution" (p 829).
- Electrophoresis 1994 15:195-199 describes poly(ethylene glycol) methacrylate- acrylamide copolymer media developed to enable electrophoresis of hydrophobic proteins.
- the authors describe increasing the speed of electrophoresis in this media by addition of 25% methanol or 30% DMF, which act as anti-freeze and allow for running gels at temperatures beginning at -20° C.
- the authors claim their system provides optimal results when the gel temperature is held at 12° C or below. Using gels containing antifreeze and starting runs at -20° C, the authors were able to apply much higher current while staying below the 12° C limit, resulting in 2 to 6-fold faster run times.
- non-gel materials As yet another example of separation systems designed for use with organic agents, non-gel materials (sponges) have been described that are compatible with organic agents (DMSO) and which are appropriate for electrophoresis of highly hydrophobic proteins [Electrophoresis 1994 15:187-194]. See also US Patent 5,637,202.
- invention methods and materials can serve to increase the rate of migration of biologic molecules in gel electrophoresis applications. As a result, the length of time required to complete a given electrophoresis run is decreased, allowing for higher data throughput in a given time period.
- the present invention has positive implications for increasing the efficiency of high-throughput biological molecule screening and characterization.
- Electrophoresis gels contemplated for use in the practice of the present invention provide advantages over gels currently employed in the art. Decreases in separation times allow for additional gels to be run in a given time period, increasing efficiency in life science laboratories. Inclusion of organic agents allows for efficient separation of proteins with strong hydrophobic character compared to gels without added organic buffer.
- inventions comprise: a) applying a mixture of biomolecules to a separation medium comprising a gellable polymeric material and a mixed medium, wherein said mixed medium comprises an aqueous component and one or more organic agents, b) applying an electric field to said separation medium, for a time sufficient to cause the electrophoretic separation of said biomolecules, according to the size and relative charge of said biomolecules.
- the aqueous component of the mixed medium contemplated for use in the practice of the present invention will comprise electrolytes in sufficient concentration, and combination, and having a suitable pH for conducting electrophoresis.
- electrolytes will depend on the gellable polymeric material being used as well as the nature of the biomolecules being separated. Those of skill in the art can readily determine the appropriate type and amount of electrolytes to be employed.
- the aqueous electrolyte-containing component contemplated for use in the practice of the present invention comprises buffered media having a pH in the range of about 2 up to 12, such aqueous components include aqueous surfactant-containing mixtures, aqueous solutions containing salt or other electrolytes, and the like.
- aqueous components include aqueous surfactant-containing mixtures, aqueous solutions containing salt or other electrolytes, and the like.
- organic agent to the separation media allows for higher running voltages at a given temperature without damage to the gel from heating. Accordingly, invention methods may be carried out at any temperature provided that the electric field applied to the gel does not damage the separation medium to an extent that prevents accurate electrophoresis. As will be understood by those of skill in the art, the accuracy of electrophoresis can be gauged by running appropriate molecular weight standards, or the like.
- application of electric field to the separation medium is conducted at or below room temperature. In another embodiment of the present invention, application of electric field to the separation medium is conducted at or above room temperature. In a presently preferred embodiment of the present invention, application of electric field to the separation medium is at room temperature. In a presently preferred embodiment, electrophoresis is conducted at a temperature range from about -20°C to room temperature (i.e., about 22°C).
- Electrophoresis according to invention methods can be conducted with the application of any suitable electric field. Accordingly, in one embodiment of the present invention, the applied electric field is in the range of about 125 V to 5000V. In another embodiment of the present invention, the applied electric field is in the range of about 1000V to 2000 V. In still another embodiment of the present invention, the applied electric field is in the range of about 2000V to 5000V. In still another embodiment of the present invention, the applied electric field is in the range of about 250V to 1000V. In a presently preferred embodiment of the present invention, the applied electric field is in the range of about 350V to 450V.
- organic agent means any organic compound which, when added to the separation medium and mixed medium described herein, will provide for faster electrophoresis. Without wanting to be bound by theory, this effect is believed to be a result of a change in conductivity in the electrophoresis system due to changed viscosity and dielectric constant of a buffer containing organic agents. Molecular species are able to migrate faster in a given electrical field under the viscosity and dielectric constant conditions formed by the inclusion of organic agents in electrophoresis buffers.
- Suitable organic agents contemplated for use in the practice of the present invention include those that are at least 5% soluble in aqueous medium, such as select alcohols, ketones, nitriles, polar aprotic solvents, ethers, carbamides, and the like.
- Alcohols contemplated for use in the practice of the present invention include those that are at least 5% soluble in aqueous medium, such as methanol, ethanol, isopropanol, phenol, m-cresol, and the like.
- Ketones contemplated for use in the practice of the present invention include those that are at least 5% soluble in aqueous medium, such as acetone, methyl ethyl ketone, ethyl ethyl ketone, acetophenone, and the like.
- Nitriles contemplated for use in the practice of the present invention include those that are at least 5% soluble in aqueous medium, such as acetonitrile, glutaronitrile, propionitrile, or the like.
- Ethers contemplated for use in the practice of the present invention include those that are at least 5% soluble in aqueous medium, such as tetrahydrofuran, dioxane, dimethyl ether, or the like.
- Carbamides contemplated for use in the practice of the present invention include those that are at least 5% soluble in aqueous medium, such as urea, tetramethyl urea (TMU), or the like.
- aqueous medium such as urea, tetramethyl urea (TMU), or the like.
- Polar aprotic solvents contemplated for use in the practice of the present invention include dimethyl formamide, dimethyl sulfoxide, chloral hydrate, formamide, benzaldehyde, ethyl acetate, N-methylacetamide, N-methylpyrrolidinone, and the like.
- the mixed medium comprises in the range of about 20 to about 99.5 wt% of aqueous component. In another embodiment of the present invention the mixed medium comprises in the range of about 60 to about 99 wt% of aqueous component. In yet another embodiment of the present invention, the mixed medium comprises in the range of about 80 to about 99 wt% of aqueous component. In a presently preferred embodiment, the mixed medium comprises about 95 wt% of aqueous component.
- the amount of organic agent in the mixed medium contemplated for use in the practice of the present invention will also vary according to the particular organic agent and gellable polymeric material employed.
- the mixed medium contains about 1-30 wt% of organic agent(s).
- the mixed medium comprises in the range of about 3 to about 20 wt% of organic agent(s).
- the mixed medium comprises in the range of about 4 to about 10 wt% of organic agent(s).
- the mixed medium comprises about 5 wt% of organic agent(s).
- methods for the rapid separation of biomolecules by size and relative charge comprising: a) applying a mixture of biomolecules to a modified separation medium comprising a gellable polymeric material and a suitable electrophoresis buffer, b) applying an electric field to said modified separation medium, for a time sufficient to cause the electrophoretic separation of said biomolecules, according to the size and relative charge of said biomolecules, wherein the viscosity and/or dielectric constant of said modified separation medium is selected such that biomolecules separate during electrophoresis therein at a more rapid rate than in unmodified separation medium.
- Suitable dielectric constants for separation media which provide more rapid separation of biomolecules typically fall in the range of about 5-75, and preferably in the range of about 10-40.
- Suitable viscosities for separation media which provide more rapid separation of biomolecules typically fall in the range of about 0.2 to 2.0 mPa s at 25°C.
- the separation medium further comprises a denaturing agent.
- a denaturing agent Any appropriate denaturing agent can be employed, including sodium dodecyl sulfate, urea, formamide, sulfolane, ⁇ -mercaptoethanol, dithiothreitol (DTT), methyl mercury, or the like.
- Biomaterial contemplated for treatment in accordance with invention separation methods include proteins, polypeptides, nucleic acids, oligonucleotides, carbohydrates, oligosaccharides, lipids, glycolipids, as well as other charged polymine materials (both natural and synthetic), and the like.
- polypeptides refer to compounds containing two or more amino acids linked covalently through peptide bonds. Polypeptides of three or more amino acids are sometimes referred to as oligopeptides.
- proteins refer to macromolecules made up of one or more chains of amino acids covalently joined through peptide bonds. Proteins can vary greatly in molecular weight, from a few thousand to several million daltons.
- nucleic acids refer to either of two major types of macromolecule (i.e., DNA or RNA) formed by polymerization of nucleotides.
- DNA and RNA exist in many forms, all of which are contemplated for use in the practice of the present invention.
- oligonucleotides refer to relatively short chain nucleic acids, i.e., from 2 to about 1000 bases in length.
- Carbohydrates refer to sugar-based compounds containing carbon, hydrogen and oxygen with the general formula C x (H O) y . Carbohydrates can be divided into various sub-groups, i.e., monosaccharides, disaccharides, oligosaccharides or polysaccharides, depending on the degree of polymerization of the basic sugar units. As employed herein, “oligosaccharides” refer to carbohydrates containing a plurality of monosaccharides. As employed herein, “lipids” refer to those compounds found in living organisms which are not carbohydrates, proteins or polynucleic acids.
- Lipids tend to be soluble in organic agents and insoluble in water, and include fats, waxes, phospholipids, glycolipids, steroids, te ⁇ enes and a number of different types of pigments.
- the major group of lipids contains those compounds whose structure is characterized by the presence of fatty acid moieties (acyl lipids). These include neutral lipids (glycerides and waxes) and polar lipids (phospholipids and glycolipids).
- acyl lipids fatty acid moieties
- lipids include neutral lipids (glycerides and waxes) and polar lipids (phospholipids and glycolipids).
- glycolipids refer to lipids that contain one or more carbohydrate moieties. These lipids include the cerebrosides and ganghosides in animals and the galactosyl diglycerides and sulpholipids in plants.
- the lipid portion is usually glycerol phosphate, gly
- the gellable polymeric material contemplated for use in the practice of the present invention may comprise thermally crosslinked gels of different monomer and crosslinker combinations selected for their suitability in separation of particular molecular species.
- Exemplary thermally crosslinked gellable polymeric materials contemplated for use in the practice of the present invention include polyacrylamide, substituted acrylamide (including, for example, N-substituted polyacrylamide, and the like), poly-N-acryloyl-tris, acrylomo ⁇ holine, HYDROLINKTM, acrylic and methacrylic esters (e.g., poly(ethylene glycol) methacrylate-acrylamide copolymer, polyhydroxy methacrylate, poly(ethylene glycol) methacrylate, and the like), poly(N-acylalkylenimine), N-vinyl pyrrolidone-based polymers, methacrylic acid-based polymers (e.g., glycerol methacrylate-based polymers,
- the gellable polymeric material contemplated for use in the practice of the present invention may comprise gels of natural or synthetic polymers which form gels through chain-entanglement processes.
- Such gellable polymeric materials include agarose (natural material) and the synthetic hydrogel materials described in United States Patent No. 5,888,365 (inco ⁇ orated herein by reference in its entirety; referred to hereinafter as "AHT hydrogel"), where the gel network formation is based on chain entanglement of the hydrophobic domains of nitrile groups in a polyacrylonitrile-polyacrylamide copolymer, greater hydrophobic character is present in gels, by virtue of the presence of the nitrile groups, than that of the conventional polyacrylamide gel material used in electrophoresis. Because of the hydrophobicity of the AHT hydrogel material, the electrophoretic process can take place at a far higher voltage (and thus speed) while the heat generated by the process can be dissipated to tolerable levels by air cooling or a simple water bath.
- electrophoresis matrices comprising chemically modified or differentially crosslinked acrylamide and other polymers have been developed for separation of biomolecules and are reviewed in Electrophoresis 1995 16:1815-1829, inco ⁇ orated herein by reference in its entirety. Many of these are compatible with organic agents and are contemplated for use in the practice of the present invention.
- Additional gellable polymeric materials contemplated for use in the practice of the present invention include electrophoresis sponges such as those comprising polyethylene, polypropylene, polytetrafluoroethylene, polyvinylidine difluoride, polynitrile, polystyrene, or the like, or two or more thereof.
- gellable polymeric materials One key property of the foregoing gellable polymeric materials is the ability to uptake a large weight percentage of aqueous medium.
- suitable materials will be sufficiently hydrophilic so as to allow the desired uptake level of aqueous medium.
- gellable polymeric materials suitable for use in the practice of the present invention are those having sufficient strength, in the presence of aqueous media, to retain the structural integrity thereof.
- Such structural integrity can be imparted by chemical linkage (e.g., covalent crosslinking, or ionic crosslinking), physical interaction (e.g., hydrogen bonding, hydrophobic interactions (such as the presence of crystalline domains), physical entanglement of polymer chains, dipolar forces, etc.), and the like.
- chemical linkage e.g., covalent crosslinking, or ionic crosslinking
- physical interaction e.g., hydrogen bonding, hydrophobic interactions (such as the presence of crystalline domains), physical entanglement of polymer chains, dipolar forces, etc.
- dipolar forces make a significant contribution to the structural integrity of the gellable polymeric material
- the pore size of the gel can be varied by appropriate modification of the chemical structure of the polymer, as well as manipulation of the electrolyte conditions (i.e., ionic strength, buffer type and pH).
- Gellable polymeric materials suitable for use in the practice of the present invention can be either ionizable or non-ionizable, so long as they meet the criteria set forth herein.
- Crosslinking agents when employed, are bifunctional compounds which serve to bridge two different polymer chains. Commonly used crosslinking agents are ⁇ , ⁇ - diolefins, which are inco ⁇ orated into the forming polymer by free radical polymerization. The degree of crosslinking imparted to the resin impacts the pore size achievable by the resulting resin. When chemical crosslinking agents are not used for the preparation of gellable polymeric material, gel pore size can be controlled by controlling the extent the gellable polymeric material is capable of chain entanglement and cohesive dipolar forces, and by controlling the electrolyte conditions (e.g., ionic strength, pH and buffer type) employed for the separation process.
- electrolyte conditions e.g., ionic strength, pH and buffer type
- the gellable polymeric material employed in the practice of the present invention forms a hydrogel, based at least in part, upon cohesive dipolar forces, the gel pore size can be varied by appropriate manipulation of the electrolyte conditions (e.g., ionic strength, buffer type and pH).
- the separation medium is comprised of gellable polymeric materials characterized as thermally crosslinked gels (e.g., polyacrylamide), said gels containing in the range of about 4% to about 30% total monomer (generally expressed as %T), said gels formed by crosslinking polyacrylamide strands with crosslinking agent (e.g., bis-acrylamide) in the range of about 2.5% to about 10% (generally known as %C).
- thermally crosslinked gels e.g., polyacrylamide
- %T total monomer
- crosslinking agent e.g., bis-acrylamide
- Addition of an organic agent in the gel buffer of the gels to achieve the benefits of enhanced separation speed has not previously been practiced. However, it has su ⁇ risingly been found that addition of about 1-30%, and more preferably 5-10% of organic agent to traditional polyacrylamide gel media is quite beneficial, presumably as a result of decreased viscosity and dielectric constant of the modified media.
- thermally crosslinked gels are equilibrated in gel buffer containing about 1-30% and more preferably about 5-10% of organic agent rather than carrying out polymerization in the presence of organic agent, in order to speed the polymerization step while retaining the beneficial aspects of inclusion of organic agents in the gel buffer.
- the ratio of gellable polymeric material to mixed medium can vary widely depending on the intended use, the size and nature of biomolecules being separated, and the like.
- separation media for use in an electrophoresis system, wherein said separation media comprises a gellable polymeric material and a mixed medium, and wherein said mixed medium comprises an aqueous component and one or more organic agents. All components in the amounts specified herein are suitable for use in the practice of this embodiment of the invention.
- invention articles useful for the separation of biological materials.
- Invention articles comprise a support having deposited thereon a layer of about 0.01-5 mm of a separation medium comprising a gellable polymeric material containing aqueous medium with added organic buffer absorbed therein, wherein said gellable polymeric material is characterized as described herein.
- articles comprising a support structure containing therein separation medium comprising gellable polymeric material containing aqueous medium with added organic buffer absorbed therein, wherein said gellable polymeric material is characterized as described herein.
- Support materials contemplated for use in preparation of invention articles include glass plates, plastic sheets, and the like.
- gellable polymeric material can be inco ⁇ orated into support structures such as columns, glass tubing, capillary tubing, glass cells, and the like.
- Suitable support structures can be constructed of a variety of materials, as can be readily determined by those of skill in the art (e.g., glass, plastic, and the like).
- the gel buffer for AHT hydrogels comprises Tris (tris (hydroxy methyl) aminomethane)-borate buffer and 0.1% SDS with or without an organic agent such as 10% acetonitrile.
- the running buffers contain Tris-glycine buffer and 0.1% SDS.
- polyacrylamide (Laemmli, 1970 Nature, 227, 680-686) gel buffer typically consists of 0.375 M Tris-HCl, pH 8.8, in the separating gel.
- the stacking gel consists of Tris-HCl, pH 6.8.
- the anode and cathode polyacrylamide running buffers Tris-glycine buffer and 0.1 % SDS.
- a series of AHT hydrogels that contained agents of decreasing dielectric constants were cast. Each gel was equilibrated in a buffer of appropriate composition for electrophoresis that included 5-20% of added organic agent such as acetonitrile, ethanol, acetone, or ethyl acetate. The gels were run without a stacking component. Gels were loaded with molecular weight standards (SIGMAMARKERTM) prepared according to the manufacturer's instructions in 2x Laemmli loading buffer and electrophoresis was performed in an electrophoresis cell made to accommodate the hydrogels. Electrophoresis was performed by applying a electric charge limited to 450 volts and 80 milliamperes to the apparatus. The electrophoresis was terminated when the leading front of bromophenol blue marker dye had migrated to a position 55 mm from the sample well.
- SIGMAMARKERTM molecular weight standards
- the time required to complete electrophoresis was recorded, and the gel was processed for staining with Coomassie Brilliant Blue stain.
- the distance (in mm) traveled by the protein markers from the sample well was measured following completion of the Coomassie Brilliant Blue staining procedure.
- the rate of electrophoretic separation (mm/min) was determined for each gel condition. In each case, gels with higher concentration of organic agent had a faster rate of separation than those with lower concentrations. For all gels with concentrations of organic agent at 10% or higher, the rate of separation was increased by 5 to 10% .
- a series of polyacrylamide gels that contained agents of decreasing dielectric constants were cast. Each 5 ml gel contained 2.5 ml of 30% monomer acrylamide/bisacrylamide (29:1; 3.3% crosslinking), 0.375 M TrisHCl, pH 8.8, 0.1% SDS and 5-10% of an organic agent such as acetonitrile, ethanol, acetone, or ethyl acetate. The gels were run without a stacking component. Gels were loaded with molecular weight standards (SIGMAMARKERTM) prepared according to the manufacturer's instructions in 2x Laemmli loading buffer and electrophoresis was performed in a BioRad Mini-PROTEAN IITM apparatus.
- SIGMAMARKERTM molecular weight standards
- the electrode buffer used was 0.025 M Tris, 0.192 M glycine, 0.1% SDS, with 125 ml in the cathodic end of the apparatus and 250 ml in the anodic end.
- the electrophoresis was performed by applying a constant 125 volts to the apparatus, and was continued until the leading front of bromophenol blue marker dye reached a point 5 mm from the bottom of the gel.
- the time required to complete electrophoresis was recorded, and the gel was processed for staining with Coomassie Brilliant Blue stain according to well-known protocols.
- the distance (in mm) traveled by the protein markers from the sample well was measured following completion of the Coomassie Brilliant Blue staining procedure.
- the rate of electrophoretic separation (mm/min) was determined for each gel condition. Gels made with acetonitrile, acetone or ethyl acetate demonstrated increased rate of separation when compared with gels run in the absence of organic agent.
- the rate of electrophoresis in a polyacrylamide gel that contained 5% acetonitrile was compared to a standard polyacrylamide gel with no added organic agent.
- Each 5 ml gel contained 2.5 ml of 30% monomer acrylamide/bisacrylamide (29:1; 3.3% crosslinking), 0.375 M TrisHCl, pH 8.8, and 0.1% SDS.
- the gels were run without a stacking component. Gels were loaded with molecular weight standards (SIGMAMARKERTM) prepared according to the manufacturer's instructions in 2x Laemmli loading buffer and electrophoresis was performed in a BioRad Mini- PROTEAN IITM apparatus.
- SIGMAMARKERTM molecular weight standards
- the electrode buffer used was 0.025 M Tris, 0.192 M glycine, 0.1% SDS, with 125 ml in the cathodic end of the apparatus and 250 ml in the anodic.
- the electrophoresis was performed by applying a constant 125 volts to the apparatus for 60 minutes, at which time the gel was processed for staining with Coomassie Brilliant Blue stain according to well-known protocols.
- the distance (in mm) traveled by the protein markers from the sample well was measured following completion of the Coomassie Brilliant Blue staining procedure.
- the rate of electrophoretic separation (mm/min) was determined for each gel condition.
- the gel made with acetonitrile demonstrated an increased rate of separation as compared to a standard polyacrylamide gel with no added organic agent.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU46758/00A AU4675800A (en) | 1999-04-30 | 2000-04-28 | Mixed buffers in gel electrophoresis systems |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13175199P | 1999-04-30 | 1999-04-30 | |
US60/131,751 | 1999-04-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000067009A1 true WO2000067009A1 (fr) | 2000-11-09 |
Family
ID=22450861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/011474 WO2000067009A1 (fr) | 1999-04-30 | 2000-04-28 | Tampons melanges dans des systemes d'electrophorese en gel |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4675800A (fr) |
WO (1) | WO2000067009A1 (fr) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1533612A1 (fr) * | 2004-07-30 | 2005-05-25 | Agilent Technologies, Inc. | Matrice de gel pour électrophorese contenant DMSO |
US6939453B2 (en) * | 2002-08-14 | 2005-09-06 | Large Scale Proteomics Corporation | Electrophoresis process using ionic liquids |
EP1167962A4 (fr) * | 1999-12-02 | 2008-08-06 | Hymo Corp | Gels de polyacrylamide premoules pour l'electrophorese, procede de production de ces derniers et procede d'electrophorese dans lequel on utilise ces gels |
US20160216232A1 (en) * | 2010-04-27 | 2016-07-28 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
WO2018217816A1 (fr) * | 2017-05-22 | 2018-11-29 | Integenx Inc. | Compositions, procédés, kits et dispositifs d'analyse moléculaire |
WO2018217789A3 (fr) * | 2017-05-22 | 2019-02-14 | Integenx Inc. | Compositions, procédés, kits et dispositifs d'analyse moléculaire |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5324401A (en) * | 1993-02-05 | 1994-06-28 | Iowa State University Research Foundation, Inc. | Multiplexed fluorescence detector system for capillary electrophoresis |
US5560811A (en) * | 1995-03-21 | 1996-10-01 | Seurat Analytical Systems Incorporated | Capillary electrophoresis apparatus and method |
US5567292A (en) * | 1993-12-17 | 1996-10-22 | The Perkin-Elmer Corporation | Polymers for separation of biomolecules by capillary electrophoresis |
US5637202A (en) * | 1993-10-27 | 1997-06-10 | California Institute Of Technology | Porous electrophoresis sponges |
US5874212A (en) * | 1993-05-13 | 1999-02-23 | Thomas Jefferson University | Detection of single base mutations and other variations in double stranded DNA by conformation-sensitive gel electrophoresis |
US5885432A (en) * | 1992-11-05 | 1999-03-23 | Soane Biosciences | Un-crosslinked polymeric media for electrophoresis |
US5888365A (en) * | 1993-11-17 | 1999-03-30 | Applied Hydrogel Technology | Methods for the separation of biological materials |
-
2000
- 2000-04-28 AU AU46758/00A patent/AU4675800A/en not_active Abandoned
- 2000-04-28 WO PCT/US2000/011474 patent/WO2000067009A1/fr active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5885432A (en) * | 1992-11-05 | 1999-03-23 | Soane Biosciences | Un-crosslinked polymeric media for electrophoresis |
US5324401A (en) * | 1993-02-05 | 1994-06-28 | Iowa State University Research Foundation, Inc. | Multiplexed fluorescence detector system for capillary electrophoresis |
US5874212A (en) * | 1993-05-13 | 1999-02-23 | Thomas Jefferson University | Detection of single base mutations and other variations in double stranded DNA by conformation-sensitive gel electrophoresis |
US5637202A (en) * | 1993-10-27 | 1997-06-10 | California Institute Of Technology | Porous electrophoresis sponges |
US5888365A (en) * | 1993-11-17 | 1999-03-30 | Applied Hydrogel Technology | Methods for the separation of biological materials |
US5567292A (en) * | 1993-12-17 | 1996-10-22 | The Perkin-Elmer Corporation | Polymers for separation of biomolecules by capillary electrophoresis |
US5560811A (en) * | 1995-03-21 | 1996-10-01 | Seurat Analytical Systems Incorporated | Capillary electrophoresis apparatus and method |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1167962A4 (fr) * | 1999-12-02 | 2008-08-06 | Hymo Corp | Gels de polyacrylamide premoules pour l'electrophorese, procede de production de ces derniers et procede d'electrophorese dans lequel on utilise ces gels |
US6939453B2 (en) * | 2002-08-14 | 2005-09-06 | Large Scale Proteomics Corporation | Electrophoresis process using ionic liquids |
EP1533612A1 (fr) * | 2004-07-30 | 2005-05-25 | Agilent Technologies, Inc. | Matrice de gel pour électrophorese contenant DMSO |
US7794576B2 (en) | 2004-07-30 | 2010-09-14 | Agilent Technologies, Inc. | Protein resolution enhancement by using matrix containing DMSO |
US20160216232A1 (en) * | 2010-04-27 | 2016-07-28 | Dgel Electrosystem Inc. | Electrophoresis buffer for faster migration, improved resolution and extended shelf-life |
WO2018217816A1 (fr) * | 2017-05-22 | 2018-11-29 | Integenx Inc. | Compositions, procédés, kits et dispositifs d'analyse moléculaire |
WO2018217789A3 (fr) * | 2017-05-22 | 2019-02-14 | Integenx Inc. | Compositions, procédés, kits et dispositifs d'analyse moléculaire |
US20200141901A1 (en) * | 2017-05-22 | 2020-05-07 | Life Technologies Corporation | Compositions, methods, kits and devices for molecular analysis |
US11619608B2 (en) | 2017-05-22 | 2023-04-04 | Life Technologies Corporation | Compositions, methods, kits and devices for molecular analysis |
US20230314369A1 (en) * | 2017-05-22 | 2023-10-05 | Life Technologies Corporation | Compositions, methods, kits and devices for molecular analysis |
US12153014B2 (en) | 2017-05-22 | 2024-11-26 | IntegenX, Inc. | Compositions, methods, kits and devices for molecular analysis |
Also Published As
Publication number | Publication date |
---|---|
AU4675800A (en) | 2000-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0638168B1 (fr) | Separation de poids moleculaire de biomolecules par electrophorese capillaire a l'aide d'une solution contenant des polymeres | |
EP0566784B1 (fr) | Gel de polyacrylamide pour l'électrophorèse | |
JP3313712B2 (ja) | 界面動電法およびクロマトグラフィー法におけるポリアクリルアミドマトリックスのための新規な配合物 | |
WO1995030782A1 (fr) | Supports de separation utilises dans l'electrophorese sur gel | |
EP1167962A1 (fr) | Gels de polyacrylamide premoules pour l'electrophorese, procede de production de ces derniers et procede d'electrophorese dans lequel on utilise ces gels | |
WO2000042423A9 (fr) | Copolymeres destines a l'electrophorese capillaire en gel | |
EP0534017A1 (fr) | Procédé électrophorétique utiliser une matrice électrophorétique | |
EP0246751B1 (fr) | Médium pour l'électrophorèse | |
JP3942001B2 (ja) | 電気泳動用ポリアクリルアミドプレキャストゲル,その製造方法及び蛋白質の分離分析方法 | |
WO2000067009A1 (fr) | Tampons melanges dans des systemes d'electrophorese en gel | |
US9150611B2 (en) | Aqueous transfer buffer | |
JPS59136648A (ja) | ゲル電気泳動用媒体 | |
US5888365A (en) | Methods for the separation of biological materials | |
AU2004260066B2 (en) | Pre-cast electrophoresis slab gels from supplemented monomer solutions | |
US20060108225A1 (en) | High conductivity sieving matrices for high resolution biomolecule separations | |
Chen et al. | Polymer solution‐filled column for the analysis of antisense phosphorothioates by capillary electrophoresis | |
JPH05322845A (ja) | ゲル充填キャピラリーカラムの調製方法 | |
Righetti et al. | [10] Isoelectric focusing in immobilized pH gradients | |
WO2020086366A1 (fr) | Procédés de séparation d'acides nucléiques de grande taille dans des conditions dénaturées | |
CA2511939C (fr) | Gels en plaques d'electrophorese pre-coules a duree de conservation longue | |
JPH05133937A (ja) | 電気泳動用支持体およびそれを用いた電気泳動法 | |
Wehr et al. | Sieving matrix selection | |
JP2003532073A (ja) | 高温条件下での生体分子の変性剤−フリー電気泳動 | |
Guttman | Rehydratable polyacrylamide gels for capillary electrophoresis | |
US20060102480A1 (en) | Apparatus and methods for performing electrophoretic separations of macromolecules |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |